首页> 外文期刊>Journal of Clinical Pharmacy and Therapeutics >A study of medication reviews to identify drug-related problems of polypharmacy patients in the Dutch nursing home setting.
【24h】

A study of medication reviews to identify drug-related problems of polypharmacy patients in the Dutch nursing home setting.

机译:一项关于药物审查的研究,旨在确定荷兰疗养院环境中的多药患者的药物相关问题。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Little is known about the extent of drug-related problems of polypharmacy patients in Dutch nursing homes. OBJECTIVES: We investigated the feasibility of teams of hospital pharmacists and nursing home physicians carrying out medication reviews. We aimed to identify the number and nature of drug-related problems of nursing home patients receiving more than nine drugs (polypharmacy). METHODS: The study was carried out in five Dutch nursing homes (n 742 beds) between October 2005 and May 2006. Ninety-one polypharmacy patients, (average age 80 years) were included. A medication review was carried out by teams consisting of one hospital pharmacist and the patient's nursing home physician with a follow-up meeting of the same team 6 weeks later. RESULTS: A total of 323 drug-related problems were identified (mean of 3.5 problems per patient). Sixty-two per cent of problems, in 87% of patients, were classified as 'unclear or not confirmed indication or need for review' of the prescribed drug. By thetime of the follow-up, a mean of 1.7 (n = 159) problems per patient had been solved and the number of drugs per patient had decreased significantly from 13.5 to 12.7 (P < 0.0001). CONCLUSIONS: The majority of patients had at least one drug prescribed for which the indication was unknown. The intervention was accompanied by a significant decrease in the number of drugs per patient, but half of the drug-related problems remained unsolved.
机译:背景:在荷兰疗养院中,关于多药房患者与药物有关的问题的程度知之甚少。目的:我们调查了医院药剂师和疗养院医师团队进行药物审查的可行性。我们旨在确定接受九种以上药物(综合药房)的疗养院患者与药物有关的问题的数量和性质。方法:该研究于2005年10月至2006年5月间在荷兰的5家疗养院(共742张床位)中进行。纳入了91名多药房患者(平均年龄80岁)。由一名医院药剂师和患者的疗养院医师组成的小组对药物进行了审查,并在6周后与该小组进行了后续会议。结果:总共鉴定出323个与药物相关的问题(平均每位患者3.5个问题)。在87%的患者中,有62%的问题被归类为处方药的“不清楚或不确定的适应症或需要复查”。截至随访时,每位患者平均解决了1.7(n = 159)个问题,每位患者的药物数量已从13.5减少到12.7(P <0.0001)。结论:大多数患者至少开了一种药物,其适应症未知。干预伴随着每名患者的药物数量显着减少,但是一半与药物有关的问题仍未解决。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号